20 May 2026
New evidence for the use of DCB
Session comprising selected EuroPCR 2026 late-breaking trials submissions
Anchorperson:
R. Byrne
Spokesperson:
M. A. Rosli
Summary
This session reviews emerging evidence supporting the use of drug-coated balloons (DCB) in complex PCI. It covers data from recent trials such as SELUTION De Novo, studies on vascular healing, restenosis patterns, long-term outcomes compared to DES, and optimal side branch treatment in bifurcation lesions.